Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NewLink Genetics Corp (NASDAQ:NLNK)

20.39
Delayed Data
As of Mar 27
 +0.30 / +1.49%
Today’s Change
9.23
Today|||52-Week Range
22.92
+98.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues5.7M2.0M15.3M12.7M
 
 
 
 
 
Depreciation And Amortization595.0K609.0K332.0K548.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses30.5M23.6M31.9M26.1M
 
 
 
 
 
Research And Development21.9M15.6M24.5M19.5M
 
 
 
 
 
Total Operating Expenses31.1M24.2M32.2M26.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.4M-22.2M-16.9M-14.0M
 
 
 
 
 
Extraordinary Charge0.00-12.3M0.000.00
 
 
Interest Expense On Debt7.0K6.0K5.0K4.0K
 
 
 
 
 
Other Expenses0.000.00-44.0K75.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.4M-34.5M-16.8M-13.8M
 
 
 
 
 
Income Taxes-1.6M-2.1M-1.3M-336.0K
 
 
 
 
 
Net Income-23.7M-32.4M-15.5M-13.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.9M28.9M29.0M29.1M
 
 
 
 
 
Shares To Calculate EPS Diluted28.9M28.9M29.0M29.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.82-$1.12-$0.54-$0.46
 
 
 
 
 
EPS Diluted-$0.82-$1.12-$0.54-$0.46